A Multicenter, Open Label, Phase 3 Study of Tabelecleucel...

Biology of Blood and Marrow Transplantation 2020 / 03 Vol. 26; Iss. 3

A Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)

Prockop, Susan E, Hiremath, Minoti, Ye, Wei, Gamelin, Laurence, Navarro, Willis H., Mahadeo, Kris Michael
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2019.12.444
Date:
March, 2020
File:
PDF, 51 KB
2020
Conversion to is in progress
Conversion to is failed